Phillip Mertz
Director/Board Member at ALPHA COGNITION INC.
Net worth: 621 632 $ as of 29/04/2024
Phillip Mertz active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ALPHA COGNITION INC. | Director/Board Member | 21/03/2021 | - |
Career history of Phillip Mertz
Former positions of Phillip Mertz
| Companies | Position | Start | End |
|---|---|---|---|
Alpha Cognition, Inc. /old/
 Alpha Cognition, Inc. /old/ Pharmaceuticals: MajorHealth Technology Alpha Cognition, Inc. engages in operation of a biopharmaceutical company focused on the development of novel therapies to treat diseases of the brain and spinal cord. It also provides research programs to find alternative ways of treating Alzheimer’s disease and Amyotrophic Lateral Sclerosis (ALS). The company is headquartered in Vancouver, Canada. | Director/Board Member | - | - |
Training of Phillip Mertz
| Harvard University | Undergraduate Degree |
Statistics
International
| Canada | 3 |
| United States | 2 |
Operational
| Director/Board Member | 3 |
| Founder | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| ALPHA COGNITION INC. | Health Technology |
| Private companies | 1 |
|---|---|
Alpha Cognition, Inc. /old/
Alpha Cognition, Inc. /old/ Pharmaceuticals: MajorHealth Technology Alpha Cognition, Inc. engages in operation of a biopharmaceutical company focused on the development of novel therapies to treat diseases of the brain and spinal cord. It also provides research programs to find alternative ways of treating Alzheimer’s disease and Amyotrophic Lateral Sclerosis (ALS). The company is headquartered in Vancouver, Canada. | Health Technology |
- Stock Market
- Insiders
- Phillip Mertz
- Experience
